Articles
EPR Academy, Part 2 of 6: The EPR Process – From Request to Reexamination Certificate
December 5, 2025
IP Updates
Federal Circuit IP Blog
Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay
May 14, 2026
Never miss an Insight.
Sign upArticles
Navigating the Future: Ensuring Patentability for AI-Assisted Innovations in the Pharmaceutical and Chemical Space Navigating the Future: Ensuring Patentability for AI-Assisted Innovations in the Pharmaceutical and Chemical Space
July/August 2025
IP LitigatorWebinar
Recent Pharmaceutical, Chemical, and Biotech Case Law on Infringement Under the Doctrine of Equivalents Recent Pharmaceutical, Chemical, and Biotech Case Law on Infringement Under the Doctrine of Equivalents
February 18, 2025
Webinar
Webinar
Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges
January 9, 2025
Webinar
Articles
Regulating International Bulk-Data Transactions: An Analysis of the DOJ's Newly Proposed Regulations, and What it May Mean for Businesses Involved in Such Transactions Regulating International Bulk-Data Transactions: An Analysis of the DOJ's Newly Proposed Regulations, and What it May Mean for Businesses Involved in Such Transactions
April 22, 2024
Articles
White House Unveils New Order to Protect Bulk Data White House Unveils New Order to Protect Bulk Data
March 6, 2024
Webinar
Recent IPR and District Court Litigation in the Life Sciences Recent IPR and District Court Litigation in the Life Sciences
July 12, 2023
Webinar
Webinar
Recent Patent Case Law in the Pharmaceutical, Chemical, and Biotech Fields Recent Patent Case Law in the Pharmaceutical, Chemical, and Biotech Fields
September 21, 2022
Webinar
Webinar
Patent Case Law Developments for Pharmaceutical, Chemical, and Biotech Companies and Practitioners Patent Case Law Developments for Pharmaceutical, Chemical, and Biotech Companies and Practitioners
March 8, 2022
Webinar
At the PTAB Blog
PTAB Challenges to Orange Book-Listed and Biologic Patents PTAB Challenges to Orange Book-Listed and Biologic Patents
September 7, 2021
Prosecution First Blog
Supremely Confusing on That Complex Word “A”; Is It Only One or Is It One or More? Supremely Confusing on That Complex Word “A”; Is It Only One or Is It One or More?
June 11, 2021
Prosecution First Blog
In Supplemental Examination, Discretion Is the Better Part of Valor In Supplemental Examination, Discretion Is the Better Part of Valor
July 29, 2019
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.